Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384209912> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4384209912 endingPage "249" @default.
- W4384209912 startingPage "237" @default.
- W4384209912 abstract "Purpose: Ranitidine hydrochloride (HCl) remains an important medication for treating acid-peptic ailments such as Gastroesophageal reflux disease (GERD). The main objective of this Post Marketing Surveillance (PMS) clinical study was to test the efficacy and safety of Ranitidine HCl in Indian patients suffering from GERD. Patients and Methods: Data of 2446 patients (1307 males; 1121 females) from 21 centers across India were analyzed. Patients received either of the three treatments: Ranitidine HCl 150 mg twice a day (BID) (ARM-A), Ranitidine HCl 300 mg once daily (OD) or BID (ARM-B), and Ranitidine HCl 300 mg OD (ARM-C). Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS) score and Heartburn Severity score were used to assess the drug’s efficacy. The adverse events reported by patients or investigators were analyzed to assess the safety profile of Ranitidine. Results: Of the 2446 subjects screened, 2428 were enrolled. There was a significant reduction in GSAS scores from baseline to the end of the study visit in all three ARMs. The GSAS scores reduced from 2.02 to 0.23 in ARM-A, 2.01 to 0.24 in ARM-B, and 2.07 to 0.26 in ARM-C patients. In ARM A, 72.82% had 24 hours heartburn-free days, and 66.89% had 7 consecutive heartburn-free days, which was more significant than the other two ARMs. 128 (5.27%) patients reported ADRs due to Ranitidine HCl at different doses. The most frequently reported ADR was constipation (17.18%), followed by oliguria (14.06%), cold (13.28%), and dysuria (12.5%). Of 128 ADRs, 113 (88.28%) were mild, and only 11 (8.59%) ADRs were related to the study drug. No severe ADRs were reported during the study. Conclusion: Ranitidine HCl 150/300 mg tablet was found to be an effective and safe H2-receptor antagonist for treating GERD in Indian Patients." @default.
- W4384209912 created "2023-07-14" @default.
- W4384209912 creator A5016808379 @default.
- W4384209912 creator A5023783027 @default.
- W4384209912 creator A5033270285 @default.
- W4384209912 creator A5034427331 @default.
- W4384209912 creator A5064761776 @default.
- W4384209912 creator A5067529044 @default.
- W4384209912 creator A5072972799 @default.
- W4384209912 creator A5074697921 @default.
- W4384209912 creator A5074810431 @default.
- W4384209912 creator A5077873968 @default.
- W4384209912 creator A5078030641 @default.
- W4384209912 creator A5086273981 @default.
- W4384209912 creator A5092465498 @default.
- W4384209912 date "2023-01-01" @default.
- W4384209912 modified "2023-09-30" @default.
- W4384209912 title "A Prospective, Multicentric, Post Marketing Surveillance to Evaluate Efficacy & Safety of Ranitidine HCl (150 & 300 mg IR/CR) in Indian Patients with Gastroesophageal Reflux Disease (PROGRADE)" @default.
- W4384209912 cites W1482976729 @default.
- W4384209912 cites W1765287762 @default.
- W4384209912 cites W1985505791 @default.
- W4384209912 cites W1987998589 @default.
- W4384209912 cites W2003744520 @default.
- W4384209912 cites W2006615766 @default.
- W4384209912 cites W2016450592 @default.
- W4384209912 cites W2023885843 @default.
- W4384209912 cites W2048560244 @default.
- W4384209912 cites W2092403130 @default.
- W4384209912 cites W2112213029 @default.
- W4384209912 cites W2473901334 @default.
- W4384209912 cites W2502104980 @default.
- W4384209912 cites W2960511348 @default.
- W4384209912 cites W3014484853 @default.
- W4384209912 cites W3094297386 @default.
- W4384209912 cites W3097756312 @default.
- W4384209912 cites W3159448204 @default.
- W4384209912 cites W3206329582 @default.
- W4384209912 doi "https://doi.org/10.4236/ojgas.2023.137022" @default.
- W4384209912 hasPublicationYear "2023" @default.
- W4384209912 type Work @default.
- W4384209912 citedByCount "0" @default.
- W4384209912 crossrefType "journal-article" @default.
- W4384209912 hasAuthorship W4384209912A5016808379 @default.
- W4384209912 hasAuthorship W4384209912A5023783027 @default.
- W4384209912 hasAuthorship W4384209912A5033270285 @default.
- W4384209912 hasAuthorship W4384209912A5034427331 @default.
- W4384209912 hasAuthorship W4384209912A5064761776 @default.
- W4384209912 hasAuthorship W4384209912A5067529044 @default.
- W4384209912 hasAuthorship W4384209912A5072972799 @default.
- W4384209912 hasAuthorship W4384209912A5074697921 @default.
- W4384209912 hasAuthorship W4384209912A5074810431 @default.
- W4384209912 hasAuthorship W4384209912A5077873968 @default.
- W4384209912 hasAuthorship W4384209912A5078030641 @default.
- W4384209912 hasAuthorship W4384209912A5086273981 @default.
- W4384209912 hasAuthorship W4384209912A5092465498 @default.
- W4384209912 hasBestOaLocation W43842099121 @default.
- W4384209912 hasConcept C126322002 @default.
- W4384209912 hasConcept C197934379 @default.
- W4384209912 hasConcept C2776462128 @default.
- W4384209912 hasConcept C2777014526 @default.
- W4384209912 hasConcept C2777445857 @default.
- W4384209912 hasConcept C2779134260 @default.
- W4384209912 hasConcept C2781112942 @default.
- W4384209912 hasConcept C43270747 @default.
- W4384209912 hasConcept C71924100 @default.
- W4384209912 hasConcept C90924648 @default.
- W4384209912 hasConceptScore W4384209912C126322002 @default.
- W4384209912 hasConceptScore W4384209912C197934379 @default.
- W4384209912 hasConceptScore W4384209912C2776462128 @default.
- W4384209912 hasConceptScore W4384209912C2777014526 @default.
- W4384209912 hasConceptScore W4384209912C2777445857 @default.
- W4384209912 hasConceptScore W4384209912C2779134260 @default.
- W4384209912 hasConceptScore W4384209912C2781112942 @default.
- W4384209912 hasConceptScore W4384209912C43270747 @default.
- W4384209912 hasConceptScore W4384209912C71924100 @default.
- W4384209912 hasConceptScore W4384209912C90924648 @default.
- W4384209912 hasIssue "07" @default.
- W4384209912 hasLocation W43842099121 @default.
- W4384209912 hasOpenAccess W4384209912 @default.
- W4384209912 hasPrimaryLocation W43842099121 @default.
- W4384209912 hasRelatedWork W1503609425 @default.
- W4384209912 hasRelatedWork W1972259282 @default.
- W4384209912 hasRelatedWork W2067205465 @default.
- W4384209912 hasRelatedWork W2087179433 @default.
- W4384209912 hasRelatedWork W2163017654 @default.
- W4384209912 hasRelatedWork W2371409254 @default.
- W4384209912 hasRelatedWork W2461403891 @default.
- W4384209912 hasRelatedWork W2476548940 @default.
- W4384209912 hasRelatedWork W3031280342 @default.
- W4384209912 hasRelatedWork W3141404013 @default.
- W4384209912 hasVolume "13" @default.
- W4384209912 isParatext "false" @default.
- W4384209912 isRetracted "false" @default.
- W4384209912 workType "article" @default.